Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Jingxing Zhike is a traditional Chinese herbal medicine formulation approved in China for the treatment of pediatric respiratory diseases, specifically acute bronchitis and tracheobronchitis. It is formulated as granules and primarily indicated for children. The product is designed to relieve cough, clear heat from the lungs, and address symptoms associated with wind-cold-heat syndrome in acute bronchitis and post-infectious cough. Its mechanism of action involves multiple herbal components that exert anti-inflammatory, antitussive (cough-suppressing), expectorant, and possibly mild antimicrobial effects typical of traditional Chinese medicine formulations. The precise molecular targets are not specified due to its multi-component nature[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoer jingxing zhike.